Top Markets
Coin of the day
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Hisse Senetlerindeki Sıralama #24699
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Hisse Fiyatı
$0.95011029
Son senkronizasyon: 2023-06-28
Piyasa Değeri
$57.72M
Değişim (1 gün)
8.53%
Değişim (1 yıl)
0.00%
Ülke
FR
Ticaret ERYTECH Pharma S.A. (ERYP)

Kategori

ERYTECH Pharma S.A. (ERYP) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.90 - 2023-06-01

Gün sonu en düşük fiyat: $14.08 - 2013-05-01
ERYTECH Pharma S.A. için hisse fiyatı geçmişi: 2013 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2023 73.43%
2022 -78.67%
2021 -73.09%
2020 82.31%
2019 -31.19%
2018 -67.04%
2017 59.44%
2016 -51.05%
2015 -15.86%
2014 158.90%
2013 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$551.23 38.69%
US
$1.06K 59.04%
NL
$146.66 459.34%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH